BrightPath Biotherapeutics Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BrightPath Biotherapeutics Co Ltd with three other
companies in this sector in Japan:
Carna Biosciences Inc
sales of 657.52 million Japanese Yen [US$6.17 million]
(365.18 million Japanese Yen [US$3.43 million]
3-D Matrix Ltd
(615.85 million Japanese Yen [US$5.78 million]
of which 100%
was Medical Products).